At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
RGC Regencell Bioscience Limited
Market Closed 10-09 16:00:00 EDT
7.35
-0.28
-3.67%
盘后7.30
-0.05-0.68%
19:48 EDT
High7.75Low7.28Vol118.72K
Open7.73D1 Closing7.63Amplitude6.16%
Mkt Cap3.63BTradable Cap135.48MTotal Shares494.49M
T/O884.36KT/O Rate0.64%Tradable Shares18.43M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Regencell Bioscience rises 9.1%
TIPRANKS  ·  10-09 00:05
Regencell Bioscience rises 9.1%
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
GlobeNewswire  ·  08-03
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
Regencell Bioscience rises 25.2%
TIPRANKS  ·  07-09
Regencell Bioscience rises 25.2%
Regencell Bioscience Holdings (RGC) Faces DOJ Scrutiny, Is The Stock Too Expensive?
Simply Wall St.  ·  07-06
Regencell Bioscience Holdings (RGC) Faces DOJ Scrutiny, Is The Stock Too Expensive?
Regencell Bioscience rises 29.6%
TIPRANKS  ·  07-02
Regencell Bioscience rises 29.6%
Regencell Bioscience falls -13.6%
TIPRANKS  ·  06-26
Regencell Bioscience falls -13.6%
Regencell Bioscience falls -14.3%
TIPRANKS  ·  06-25
Regencell Bioscience falls -14.3%
S&P 500 Futures Decline In Premarket Trading; Primoris Services, Tower Semiconductor Lag
Dow Jones  ·  06-23
S&P 500 Futures Decline In Premarket Trading; Primoris Services, Tower Semiconductor Lag
Regencell Bioscience falls -14.7%
TIPRANKS  ·  06-18
Regencell Bioscience falls -14.7%
Regencell Bioscience Holdings (RGC) Stock Valuation After Securities Class Action Raises Fresh Concerns
Simply Wall St.  ·  06-16
Regencell Bioscience Holdings (RGC) Stock Valuation After Securities Class Action Raises Fresh Concerns
Regencell Bioscience Holdings (RGC) Is Down 11.5% After DOJ Subpoena Spurs Class Actions Over Alleged Misstatements – Has The Bull Case Changed?
Simply Wall St.  ·  06-10
Regencell Bioscience Holdings (RGC) Is Down 11.5% After DOJ Subpoena Spurs Class Actions Over Alleged Misstatements – Has The Bull Case Changed?
A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Subpoena And Shareholder Class Actions
Simply Wall St.  ·  06-05
A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Subpoena And Shareholder Class Actions
RGC Resources Establishes New $15 Million Term Loan
TIPRANKS  ·  06-05
RGC Resources Establishes New $15 Million Term Loan
Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio?
Benzinga  ·  05-31
Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio?
Regencell Bioscience closes USD 20 million registered direct share offering
Reuters  ·  05-22
Regencell Bioscience closes USD 20 million registered direct share offering
Regencell Bioscience faces shareholder class action over alleged stock manipulation risks
Reuters  ·  05-21
Regencell Bioscience faces shareholder class action over alleged stock manipulation risks
RGC Resources Balances Earnings Strength and New Risks
TIPRANKS  ·  05-20
RGC Resources Balances Earnings Strength and New Risks
Regencell Bioscience prices 985,222-share registered direct offering at $20.30 per share
Reuters  ·  05-19
Regencell Bioscience prices 985,222-share registered direct offering at $20.30 per share
Regencell FY26 H1 net loss widens 187% to $5.3 million
Reuters  ·  05-09
Regencell FY26 H1 net loss widens 187% to $5.3 million
Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures
TIPRANKS  ·  05-07
Regencell Bioscience Holdings Faces Federal Securities Lawsuit Over Alleged Market Manipulation Disclosures

Introduction

Company Name.
Regencell Bioscience Limited
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Issue price:
--